91视频

?
?
?
Home Tags Posts tagged with "Zhang Nan"

Tag: Zhang Nan

Income indicators and risks for pharma IPOs

By Zhang Nan, W&H Law Firm

How income indicators and sales expenses impact risks in pharmaceutical IPOs under regulatory scrutiny

Correspondents

AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners
SEC and the cost of local capital market investment

SEC and the cost of local capital market investment

By Luke Morgan B Codilla, ACCRALAW
Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners

Follow us on LinkedIn